Recent Advances and Challenges in the Treatment of Major Depressive Disorder
This book reviews all aspects of major depressive disorder (MDD), casting light on its neurobiological underpinnings and describing the most recent advances in management. The book is divided into four sections, the first of which discusses MDD from a network science perspective, highlighting the al...
Na minha lista:
| Autor Corporativo: | |
|---|---|
| Outros Autores: | |
| Formato: | Recurso Electrónico livro electrónico |
| Idioma: | inglês |
| Publicado em: |
Singapore :
Springer Nature Singapore : Imprint: Springer,
2024.
|
| Edição: | 1st ed. 2024. |
| Colecção: | Advances in Experimental Medicine and Biology,
1456 |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1007/978-981-97-4402-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-981-97-4402-2 | ||
| 003 | DE-He213 | ||
| 005 | 20250807143354.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 240912s2024 si | s |||| 0|eng d | ||
| 020 | |a 9789819744022 |9 978-981-97-4402-2 | ||
| 024 | 7 | |a 10.1007/978-981-97-4402-2 |2 doi | |
| 050 | 4 | |a RC321-580 | |
| 072 | 7 | |a PSAN |2 bicssc | |
| 072 | 7 | |a SCI089000 |2 bisacsh | |
| 072 | 7 | |a PSAN |2 thema | |
| 082 | 0 | 4 | |a 612.8 |2 23 |
| 245 | 1 | 0 | |a Recent Advances and Challenges in the Treatment of Major Depressive Disorder |h [electronic resource] / |c edited by Yong-Ku Kim. |
| 250 | |a 1st ed. 2024. | ||
| 264 | 1 | |a Singapore : |b Springer Nature Singapore : |b Imprint: Springer, |c 2024. | |
| 300 | |a XXI, 426 p. 13 illus., 8 illus. in color. |b online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 341 | 0 | |b Table of contents navigation |2 onix | |
| 341 | 0 | |b Single logical reading order |2 onix | |
| 341 | 0 | |b Short alternative textual descriptions |2 onix | |
| 341 | 0 | |b Use of color is not sole means of conveying information |2 onix | |
| 341 | 0 | |b Use of high contrast between text and background color |2 onix | |
| 341 | 0 | |b Next / Previous structural navigation |2 onix | |
| 341 | 0 | |b All non-decorative content supports reading without sight |2 onix | |
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a Advances in Experimental Medicine and Biology, |x 2214-8019 ; |v 1456 | |
| 505 | 0 | |a Part I. Molecular Biology-based Treatment for Depression -- Chapter 1. Neuroendocrinological Treatment Targets for Depressive Disorder -- Chapter 2. Psychophamacological Approaches for Neural Plasticity and Neurogenesis in Major Depressive Disorder -- Chapter 3. Efficacy, Safety and Tolerability of Psychedelics in Treatment Resistant Depression (TRD) -- Chapter 4. Probiotics and Fecal Microbiota Transplantation in Major Depression: Doxa or Episteme? -- Chapter 5. Induced Pluripotent Stem Cells (iPSC) Technology for Major Depression -- Chapter 6. Combining Complementary and Alternative Medicine (CAM) with Conventional Treatments for Major Depressive Disorder -- Part II. Brain Network-based Treatments for Depression -- Chapter 7. Application of Transcranial Direct and Alternating Current Stimulation (tDCS & tACS) on Major Depressive Disorder -- Chapter 8. Repetitive Transcranial Magnetic Stimulation (rTMS) in Major Depression -- Chapter 9. Deep Brain Stimulation (DBS) in Treatment-resistant Depression (TRD): Hope and Concern -- Chapter 10. Electroconvulsive Therapy (ECT) in Major Depression: Oldie but Goodie -- Part III. Psychological Intervention based Treatments for Depression -- Chapter 11. Cognitive Behavioral Therapy and Mindfulness-based Cognitive Therapy for Depressive Disorders: Enhancing Access and Tailoring Interventions in Diverse Settings -- Chapter 12. Acceptance and Commitment Therapy for Major Depressive Disorder: Navigating Depression Treatment in Traditional and Digital Settings with Insights from Current Research -- Chapter 13. The Importance of Psychotherapy for Treatment Resistant Depression -- Chapter 14. Personalized Well-Being Therapy (WBT) for Major Depression -- Part IV. Digital Psychiatry based Treatments for Depression -- Chapter 15. The Potential and Challenges of Virtual Reality as an Adjunctive Treatment of Depression Patients -- Chapter 16. The New Emerging Treatment Choice for Major Depressive Disorders: Digital Therapeutics -- Chapter 17. Telepsychiatry in the Treatment of Major Depressive Disorders -- Part V. Personalized Precision Treatments for Depression -- Chapter 18. Precision Medicine in Depression: The Role of Proteomics and Metabolomics in Personalized Treatment Approaches -- Chapter 19. Biomarker Guided Tailored Therapy in Major Depression -- Chapter 20. Navigating the Intersection of Technology and Depression Precision Medicine. | |
| 520 | |a This book reviews all aspects of major depressive disorder (MDD), casting light on its neurobiological underpinnings and describing the most recent advances in management. The book is divided into four sections, the first of which discusses MDD from a network science perspective, highlighting the alterations in functional and structural connectivity and presenting insights achieved through resting state functional MRI and the development of neuroimaging-based biomarkers. The second section examines important diagnostic and neurobiological issues, while the third considers the currently available specific treatments for MDD, including biofeedback, neurofeedback, cognitive behavioral therapy, acceptance and commitment therapy, neuromodulation therapy, psychodynamic therapy, and complementary and alternative medicine. A concluding section is devoted to promising emerging treatments, from novel psychopharmacological therapies through to virtual reality treatment, immunotherapy, biomarker-guided tailored therapy, and more. Written by leading experts from across the world, the book will be an excellent source of information for both researchers and practitioners. | ||
| 532 | 8 | |a Accessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. | |
| 532 | 8 | |a No reading system accessibility options actively disabled | |
| 532 | 8 | |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com | |
| 650 | 0 | |a Neurosciences. | |
| 650 | 0 | |a Medicine |x Research. | |
| 650 | 0 | |a Biology |x Research. | |
| 650 | 0 | |a Physiology. | |
| 650 | 0 | |a Clinical medicine |x Research. | |
| 650 | 1 | 4 | |a Neuroscience. |
| 650 | 2 | 4 | |a Biomedical Research. |
| 650 | 2 | 4 | |a Physiology. |
| 650 | 2 | 4 | |a Clinical Research. |
| 700 | 1 | |a Kim, Yong-Ku. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9789819744015 |
| 776 | 0 | 8 | |i Printed edition: |z 9789819744039 |
| 776 | 0 | 8 | |i Printed edition: |z 9789819744046 |
| 830 | 0 | |a Advances in Experimental Medicine and Biology, |x 2214-8019 ; |v 1456 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-981-97-4402-2 |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||